NetworkNewsBreaks

ThursdayJul 10, 2025 11:17 am

NetworkNewsBreaks – SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Positions for Growth Under Shifting U.S. and Canadian Clean Energy Policies 

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a North American solar and battery storage developer, announced strategic readiness to capitalize on clean energy incentives in both the U.S. and Canada. In response to the new “Big Beautiful Bill” federal legislation, which extends investment tax credits for projects started by July 4, 2026, SolarBank plans to accelerate construction on a 97 MW U.S. portfolio backed by $100 million in project financing from CIM Group. The company is advancing projects in key U.S. states with favorable permitting and interconnection progress to qualify under the new…

Continue Reading

ThursdayJul 10, 2025 9:30 am

NetworkNewsBreaks – ONAR Holding Corp. (OTCQB: ONAR) to Present on AI-Driven Commerce at GenAI Week Silicon Valley 2025

ONAR (OTCQB: ONAR), a marketing-technology company and agency network, announced that CEO Claude Zdanow will deliver a keynote at GenAI Week Silicon Valley 2025. His talk, “From SEO to LMO: How AI Language Models Are Rewriting the Rules of AI-Driven Digital Commerce,” is scheduled for July 14 from 12:00 to 12:20 p.m. PDT on the Align Stage. Zdanow will outline how Language Model Optimization (LMO) is replacing traditional SEO and share four key strategies for brands to succeed in the evolving AI-first commerce landscape. GenAI Week, taking place July 13–17 at the Santa Clara Convention Center, will host over 30,000…

Continue Reading

ThursdayJul 10, 2025 9:30 am

NetworkNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Completes Historic REVIVE Trial, Sets Stage for Long COVID Breakthrough and Market Expansion 

Fifty 1 Labs (OTC: FITY), through its subsidiary Fifty1 AI Labs, LLC, announced the successful completion of the REVIVE Adaptive Platform Trial (NCT06128967), a groundbreaking Phase III study and the largest Long COVID trial to date. Conducted with global partners and top institutions including Stanford and Duke, the randomized, double-blind trial enrolled over 600 participants and demonstrated a clear treatment benefit using repurposed medicines. Powered by FITY’s proprietary AI platform, the trial sets a new standard in drug repurposing and personalized medicine, while supporting the company’s broader strategy to lead the $320.6 billion functional medicine market, pursue strategic acquisitions, and…

Continue Reading

ThursdayJul 10, 2025 9:10 am

NetworkNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Completes Historic REVIVE Trial, Sets Stage for Long COVID Breakthrough and Market Expansion

Fifty 1 Labs (OTC: FITY), through its subsidiary Fifty1 AI Labs, LLC, announced the successful completion of the REVIVE Adaptive Platform Trial (NCT06128967), a groundbreaking Phase III study and the largest Long COVID trial to date. Conducted with global partners and top institutions including Stanford and Duke, the randomized, double-blind trial enrolled over 600 participants and demonstrated a clear treatment benefit using repurposed medicines. Powered by FITY’s proprietary AI platform, the trial sets a new standard in drug repurposing and personalized medicine, while supporting the company’s broader strategy to lead the $320.6 billion functional medicine market, pursue strategic acquisitions, and…

Continue Reading

ThursdayJul 10, 2025 9:00 am

NetworkNewsBreaks – Fusion Fuel Green PLC (Nasdaq: HTOO) Announces 1-for-35 Reverse Share Split to Regain Nasdaq Compliance

Fusion Fuel Green (Nasdaq: HTOO) today announced a 1-for-35 reverse share split of its Class A Ordinary Shares, effective at market open on Monday, July 14, 2025. The split is intended to restore compliance with Nasdaq’s minimum bid price requirement. Following the split, the number of outstanding Class A shares will decrease from approximately 27.4 million to 783,376, with the new CUSIP number G3R25D 209. No fractional shares will be issued, and any resulting fractions will be rounded up. Shareholders are not required to take action, as changes will be automatically reflected in accounts. The authorized share capital will remain…

Continue Reading

WednesdayJul 09, 2025 2:57 pm

NetworkNewsBreaks – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Advances Portfolio in Walker Lane Hotspot

As Nevada’s Walker Lane becomes a prime target for mineral exploration, Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) is strategically positioned to capitalize, owning and developing four high-potential exploration properties in the area. “With a vision to evolve into Nevada’s premier silver and gold producer, Lahontan has built a robust portfolio of assets across this geologically diverse and historically rich trend,” reads a recent article. “The company controls four properties in the heart of Walker Lane: Santa Fe, West Santa Fe, Moho and Redlich. The company’s flagship project, the Santa Fe Mine, is a 26.4 km2 past-producing, oxide-hosted gold-silver property. Between 1988 and 1995,…

Continue Reading

WednesdayJul 09, 2025 1:25 pm

NetworkNewsBreaks – Adageis’ Platform Tackles Healthcare Complexities with AI

Adageis was featured in a recent article that discussed its powerful and patented AI-centric software solution. “Healthcare is a complicated place, and navigating the system is extremely difficult for patients,” Adageis’ CEO Shane Speirs was quoted as saying. “What Adageis does is provide a simple solution to healthcare organizations, ranging from large, multi-state, multi-specialty healthcare groups to independent practices across the country. We offer a solution that meets everyone’s needs, helping providers and organizations drive revenue by delivering high-quality care, which everyone can align with.” To view the full article, visit https://nnw.fm/OsbJv About Adageis Adageis is a healthcare technology innovator focused…

Continue Reading

WednesdayJul 09, 2025 11:32 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Lead Program in Virtual CEO Segment 

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company focused on treating primary and metastatic cancers in the brain and central nervous system, announced CEO John Climaco’s participation in a Virtual Investor CEO Connect segment. Climaco provided an overview of the Company’s lead candidate, TPI 287, and shared insights from the Longwood Healthcare Leaders Spring 2025 Meeting in Cambridge, Massachusetts. To view the full press release, visit https://nnw.fm/wo5J2 About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The…

Continue Reading

WednesdayJul 09, 2025 11:12 am

NetworkNewsBreaks – Nicola Mining Inc. (TSX.V: NIM) (FSE: HLIA) (OTCQB: HUSIF) Begins Long-Term Gold, Silver Production at Merritt Mill 

Nicola Mining (TSX.V: NIM) (FSE: HLIA) (OTCQB: HUSIF) has commenced gold and silver concentrate production at its Merritt Mill in British Columbia, transitioning from trial processing to long-term operations. This milestone follows the receipt of a 3,100-tonne high-grade ore shipment from Talisker Resources Ltd. (TSX: TSK) (OTCQX: TSKFF), which is advancing development at its Mustang Project. Nicola’s upgraded mill features automation, gravity separation and water recirculation systems. The company has also partnered with Blue Lagoon Resources (CSE: BLLG) (OTCQB: BLAGF) (FSE: 7BL) and is preparing to process bulk samples from the Dominion Creek Gold Project, where it holds a 75%…

Continue Reading

WednesdayJul 09, 2025 10:43 am

NetworkNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Sees Growth Ahead with AI Drone Tech Following $33 Billion Federal Defense Bill 

Safe Pro Group (NASDAQ: SPAI) announced that the recently enacted One Big Beautiful Bill Act (OBBBA), which allocates $33 billion in U.S. government spending for drones and AI, presents major growth opportunities for its AI-powered drone imagery analysis technology. The Company’s SPOTD platform, which can detect over 150 types of explosive threats in real time, is already deployed in conflict zones like Ukraine and is being integrated into the U.S. Army’s ATAK system. With $13.5 billion earmarked for unmanned systems and $16 billion for AI initiatives across defense and border operations, Safe Pro aims to expand its work with the…

Continue Reading